Market Overview:
Market
Research Future (MRFR) reports that the U.S. Direct Anterior
Approach Market Size is deemed to surpass a valuation of USD 2.52 Billion during
the forecast period (2023-2032).
The
U.S. direct anterior hip approach market has witnessed significant growth in
recent years, driven by a rising preference for minimally invasive surgical
techniques among both patients and surgeons. This approach, often referred to
as the direct anterior approach (DAA), involves accessing the hip joint from
the front of the body, allowing surgeons to operate with less disruption to
surrounding muscles and tissues compared to traditional hip replacement
methods. As a result, patients may experience faster recovery times, reduced
post-operative pain, and improved mobility. This approach has gained popularity
due to its potential to minimize tissue damage, leading to shorter hospital
stays and decreased rehabilitation periods, which can contribute to overall
cost savings for the healthcare system.
Additionally,
technological advancements in surgical instruments and imaging techniques have
further facilitated the adoption of the direct anterior hip
approach in the U.S. market. Surgeons are increasingly utilizing
specialized equipment designed specifically for DAA procedures, such as custom
retractors and fluoroscopy systems, to enhance surgical precision and patient
outcomes. Moreover, the growing aging population in the United States, coupled
with an increasing prevalence of hip-related conditions such as osteoarthritis,
continues to drive demand for hip replacement surgeries, further fueling the
growth of the direct anterior approach market. As both patients and healthcare
providers increasingly recognize the benefits of minimally invasive techniques
like the direct anterior approach, the market is expected to continue its
expansion in the foreseeable future.
Segmental Analysis
According
to the extensive report, the U.S. Direct Anterior Approach Market \ in
ambulatory surgical centers (ASC) market is segmented on the basis of U.S.
total hip replacement, U.S. total hip replacement by direct anterior approach
(DAA), and U.S. total hip replacement for DAA in ASC. The U.S. Total Hip
Replacement by DAA segment is booming aggressively as this form of surgery
reduces recovery time resulting in decreased hospital stay, and less scarring
is observed. It can touch a valuation of USD 4,926.5 million by 2023, growing
at a 6.1% CAGR during the forecast period.
Competitive Dashboard
Prominent U.S. Direct Anterior
Approach Companies are
Proliance
Surgeons, OrthAlign, Inc., Smith & Nephew, Zimmer Biomet, Stryker,
Orthoillinois, Bone & Joint Surgery Clinic, Centre for Special Surgery, The
Hip and knee center, and Johnson & Johnson Services Inc. (DePuy Synthes),
and others.
Regional Outlook
The
U.S. Direct Anterior Approach Market Outlook has been on an upward trajectory
owing to rising demand for minimally invasive procedures. The associated
advantages with minimally invasive surgeries can boost market growth during the
forecast period in the United States. Moreover, key manufacturers are focusing
on technological advances and are striving to expand their geographical
outreach to strengthen their market position.
Continuous
innovation is one of the aspects these players are leveraging for competitive
gains, leading to the scaling of the market in the U.S. In addition, increasing
incidence of injuries and rising cases of obesity can fuel market growth. The
presence of high-quality healthcare system has been paramount in boosting the
market in the region. Product launches by key manufacturers are keeping the
market afloat. For instance, in June 2018, OrthoGrid Systems launched HipGrid
NINE for outpatient total hip replacement, which enables greater utility for
C-arm imaging systems often found in ambulatory surgery centers and hospitals.
Related
Reports-
For more information, Please Visit us @ Market Research Future
